1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Strongyloidiasis Global Clinical Trials Review, H2, 2016

Strongyloidiasis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Strongyloidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Strongyloidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Strongyloidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Strongyloidiasis Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2


Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in Central and South America 10
Clinical Trials by G7 Countries: Proportion of Strongyloidiasis to Infectious Disease Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
Clinical Trials by Trial Status 15
Clinical Trials by End Point Status 16
Subjects Recruited Over a Period of Time 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in Strongyloidiasis Therapeutics Clinical Trials 20
Prominent Drugs 21
Clinical Trial Profile Snapshots 22
Appendix 29
Abbreviations 29
Definitions 29
Research Methodology 30
Secondary Research 30
About GlobalData 31
Contact Us 31
Disclaimer 31
Source 32

List of Tables
Strongyloidiasis Therapeutics, Global, Clinical Trials by Region, 2016* 5
Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 10
Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 11
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase, 2016* 14
Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 16
Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 17
Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 18
Strongyloidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19
Strongyloidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 20
Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 21

List of Figures
Strongyloidiasis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 10
Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 11
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 14
Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 16
Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 17
Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 18
Strongyloidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19
Strongyloidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 20
Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 21
GlobalData Methodology 30

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.